Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Mon, 03rd Nov 2014 06:15

UK Earnings, Trading Statements Calendar 
Monday, November 3 
HSBC HoldingsInterim Management Statement
Telecity GroupInterim Management Statement
Tuesday, November 4 
Advanced Computer Software GroupHalf Year Results
Associated British FoodsFull Year Results
Legal & General GroupInterim Management Statement
GlencoreInterim Management Statement
Weir GroupInterim Management Statement
Hilton Food GroupInterim Management Statement
Imperial Tobacco GroupFull Year Results
Jardine Lloyd Thompson GroupInterim Management Statement
PersimmonInterim Management Statement
Unite GroupInterim Management Statement
OneSavings BankInterim Management Statement
888 HoldingsTrading Update
Wednesday, November 5 
Lancashire HoldingsQ3 Results
First DerivativesHalf Year Results
Avocet MiningInterim Management Statement
MeggittInterim Management Statement
Marks & Spencer GroupHalf Year Results
FirstGroupHalf Year Results
Mithras Investment TrustInterim Management Statement
Old MutualInterim Management Statement
JD WetherspoonInterim Management Statement
WincantonInterim Management Statement
HuntingHalf Year Results
MarshallsInterim Management Statement
Drax GroupInterim Management Statement
esure GroupInterim Management Statement
AlentInterim Management Statement
Thursday, November 6 
Promethean WorldInterim Management Statement
Tate & LyleHalf Year Results
Shanks GroupHalf Year Results
Dairy CrestHalf Year Results
Coca-Cola HBC AGQ3 Results
AstraZenecaQ3 Results
STV GroupInterim Management Statement
Croda InternationalInterim Management Statement
DS SmithTrading statement
Costain GroupInterim Management Statement
Intu PropertieInterim Management Statement
ExperianHalf Year Results
BeazleyInterim Management Statement
Cable & Wireless CommunicationsHalf Year Results
Halfords GroupHalf Year Results
InmarsatQ3 Results
London MiningInterim Management Statement
Randgold ResourcesQ3 Results
RightmoveInterim Management Statement
RSA Insurance GroupInterim Management Statement
SchrodersInterim Management Statement
SynthomerInterim Management Statement
WM Morrison SupermarketsInterim Management Statement
Hikma PharmaceuticalsInterim Management Statement
CobhamInterim Management Statement
Stock Spirits GroupInterim Management Statement
SuperGroupTrading statement
Friday, November 7 
Croda InternationalInterim Management Statement
Scottish Mortgage Investment TrustHalf Year Results
Spirax-Sarco EngineeringHalf Year Results
Ark Therapeutics GroupInterim Management Statement
Capital & RegionalInterim Management Statement
Rentokil InitialTrading statement
Admiral GroupInterim Management Statement
National GridHalf Year Results
Capital & Counties PropertiesInterim Management Statement
Bovis Homes GroupInterim Management Statement
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.